TRICHLORMETHIAZIDE W/ RESERPINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trichlormethiazide W/ Reserpine, and what generic alternatives are available?
Trichlormethiazide W/ Reserpine is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in TRICHLORMETHIAZIDE W/ RESERPINE is reserpine; trichlormethiazide. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine; trichlormethiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRICHLORMETHIAZIDE W/ RESERPINE?
- What are the global sales for TRICHLORMETHIAZIDE W/ RESERPINE?
- What is Average Wholesale Price for TRICHLORMETHIAZIDE W/ RESERPINE?
Summary for TRICHLORMETHIAZIDE W/ RESERPINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| DailyMed Link: | TRICHLORMETHIAZIDE W/ RESERPINE at DailyMed |
US Patents and Regulatory Information for TRICHLORMETHIAZIDE W/ RESERPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | TRICHLORMETHIAZIDE W/ RESERPINE | reserpine; trichlormethiazide | TABLET;ORAL | 085248-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
